Vaccins antigrippaux (usage thérapeutique) < Vaccins antigrippaux (économie) < Vaccins antiméningococciques (usage thérapeutique)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Vaccins antigrippaux (économie)

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000004 (2019)	Gokul Raj Pullagura ; Nancy M. Waite ; Sherilyn K D. Houle ; Richard Violette ; William W L. Wong	Cost-utility analysis of offering a novel remunerated community pharmacist consultation service on influenza vaccination for seniors in Ontario, Canada.
000035 (2019)	Andrew J. Leidner [États-Unis] ; Neil Murthy [États-Unis] ; Harrell W. Chesson [États-Unis] ; Matthew Biggerstaff [États-Unis] ; Charles Stoecker [États-Unis] ; Aaron M. Harris [États-Unis] ; Anna Acosta [États-Unis] ; Kathleen Dooling [États-Unis] ; Carolyn B. Bridges [États-Unis]	Cost-effectiveness of adult vaccinations: A systematic review.
000096 (2017)	Edward W. Thommes [Canada] ; Morgan Kruse [États-Unis] ; Michele Kohli [Canada] ; Rohita Sharma [Canada] ; Stephen G. Noorduyn [Canada]	Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
000163 (2016)	Corwin A. Robertson [États-Unis] ; Carlos A. Diazgranados [États-Unis] ; Michael D. Decker [États-Unis] ; Ayman Chit [États-Unis, Canada] ; Monica Mercer [États-Unis] ; David P. Greenberg [États-Unis]	Fluzone® High-Dose Influenza Vaccine.
000237 (2015)	Edward W. Thommes [Canada] ; Afisi Ismaila [Canada] ; Ayman Chit [Canada] ; Genevieve Meier [Belgique] ; Christopher T. Bauch [Canada]	Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
000248 (2015)	Ayman Chit [Canada] ; Julie Roiz [Royaume-Uni] ; Samuel Aballea [France]	An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model.
000252 (2015)	Alison K. Thompson [Canada] ; Maxwell J. Smith ; Christopher W. Mcdougall ; Cécile Bensimon ; Daniel Felipe Perez	"With human health it's a global thing": Canadian perspectives on ethics in the global governance of an influenza pandemic.
000256 (2014)	Ayman Chit [Canada] ; Jayson Parker [Canada] ; Scott A. Halperin [Canada] ; Manny Papadimitropoulos [Canada] ; Murray Krahn [Canada] ; Paul Grootendorst [Canada]	Toward more specific and transparent research and development costs: the case of seasonal influenza vaccines.
000479 (2012)	Ali Asgary [Canada]	Assessing households' willingness to pay for an immediate pandemic influenza vaccination programme.
000488 (2011)	Chris Skedgel [Canada] ; Joanne M. Langley ; Noni E. Macdonald ; Jeff Scott ; Shelly Mcneil	An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.
000555 (2011)	David N. Fisman [Canada] ; Ashleigh R. Tuite	Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada.
000568 (2011)	Elizabeth Rolland-Harris ; Martin Tepper	Cost-effectiveness of Ontario's pandemic vaccine program.
000589 (2011)	Jennifer A. Pereira [Canada] ; Julie Foisy ; Jeffrey C. Kwong ; Christine L. Heidebrecht ; Susan Quach ; Sherman D. Quan ; Maryse Guay ; Beate Sander	A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.
000649 (2010)	Ashleigh R. Tuite [Canada] ; David N. Fisman ; Jeffrey C. Kwong ; Amy L. Greer	Optimal pandemic influenza vaccine allocation strategies for the Canadian population.
000652 (2010)	Beate Sander [Canada] ; Chris T. Bauch ; David Fisman ; Robert A. Fowler ; Jeffrey C. Kwong ; Andreas Maetzel ; Allison Mcgeer ; Janet Raboud ; Damon C. Scales ; Marija Zivkovic Gojovic ; Murray Krahn	Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
000674 (2010)	Beate Sander [Canada] ; Jeffrey C. Kwong ; Chris T. Bauch ; Andreas Maetzel ; Allison Mcgeer ; Janet M. Raboud ; Murray Krahn	Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.
000708 (2009)	Nicola J. Mercer	Cost analysis of public health influenza vaccine clinics in Ontario.
000914 (2006)	Danuta M. Skowronski [Canada] ; John C. Woolcott ; S Aleina Tweed ; Robert C. Brunham ; Fawziah Marra	Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
000968 (2005)	Laura Eggertson	Countries ill-prepared for influenza pandemic.
000A11 (2003)	Yan Jin ; Keumhee C. Carriere ; Gerry Predy ; David H. Johnson ; Thomas J. Marrie	The association between influenza immunization coverage rates and hospitalization for community-acquired pneumonia in Alberta.
000A66 (2001)	A. Linde	[Sweden behind when it comes to influenza vaccination. Better vaccination programs in many western countries].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Vaccins antigrippaux (économie)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Vaccins antigrippaux (économie)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeCanadaV4
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Vaccins antigrippaux (économie)
}}

---

This area was generated with Dilib version V0.6.35. Data generation: Sat Aug 8 18:52:12 2020. Site generation: Sat Feb 13 16:40:04 2021